ArticleJournal of perinatology : official journal of the California Perinatal Association2026
Sweeter recovery, less intravenous fluids: a NICU quality improvement initiative for managing neonatal hypoglycemia.
Article in Journal of perinatology : official journal of the California Perinatal Association, 2026. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
0 citing papers in PubMed.
No citing paper in PubMed yet.
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
3 authors.
Funding
No grant is acknowledged in the PubMed record.
Abstract
backgroundNeonatal hypoglycemia is a common reason for neonatal intensive care unit (NICU) admission. Management variations may prolong intravenous (IV) dextrose use and NICU length of stay (LOS).
methodsWe aimed to reduce IV dextrose duration for hypoglycemic neonates transferred to the NICU by 30%. Standardization efforts included multidisciplinary team formation, guideline development, Epic SmartPhrase creation, and education. Our primary outcome measure was IV dextrose infusion duration. Secondary outcomes were LOS, percentage of patients started on IV dextrose, and number of blood draws. The process measure was guideline utilization. Balancing measures were readmissions, second IV courses, and dextrose boluses.
resultsMean IV dextrose administration decreased from 25 to 16 h and LOS from 59 to 27 h. The number of blood draws and boluses decreased without changes in readmissions or second IV dextrose courses.
conclusionsOur quality initiative safely reduced IV dextrose duration and NICU LOS, without significant rebound hypoglycemia.
Indexed as
Identifiers
42020768What OpenQuestion holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.